References
- Ruzicka FJ, Beinert H. A new iron-sulfur flavoprotein of the respiratory chain. A component of the fatty acid beta oxidation pathway. J Biol Chem. 1977;252(23):8440–8445.
- Watmough NJ, Frerman FE. The electron transfer flavoprotein: ubiquinone oxidoreductases. Biochim Biophys Acta 2010;1797(12):1910–1916.
- Gregersen N. Riboflavin-responsive defects of beta-oxidation. J Inherit Metab Dis. 1985;8 (Suppl 1):65–69.
- Olsen RK, Andresen BS, Christensen E, et al. Clear relationship between ETF/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency. Hum Mutat. 2003;22(1):12–23.
- Yotsumoto Y, Hasegawa Y, Fukuda S, et al. Clinical and molecular investigations of Japanese cases of glutaric acidemia type 2. Mol Genet Metab. 2008;94(1):61–67.
- Zhuo Z, Jin P, Li F, et al. A case of late-onset riboflavin responsive multiple acyl-CoA dehydrogenase deficiency (MADD) with a novel mutation in ETFDH gene. J Neurol Sci. 2015;353(1–2):84–86.
- Angelini C, Tavian D, Missaglia S. Heterogeneous phenotypes in lipid storage myopathy due to ETFDH gene mutations. JIMD Rep. 2018;38:33–40.
- Fu HX, Liu XY, Wang ZQ, et al. Significant clinical heterogeneity with similar ETFDH genotype in three Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency. Neurol Sci. 2016;37:1099–1105.
- Wang Z, Hong D, Zhang W, et al. Severe sensory neuropathy in patients with adult-onset multiple acyl-CoA dehydrogenase deficiency. Neuromuscul Disord. 2016;26(2):170–175.
- Peng Y, Zhu M, Zheng J, et al. Bent spine syndrome as an initial manifestation of late-onset multiple acyl-CoA dehydrogenase deficiency: a case report and literature review. BMC Neurol. 2015;15(1):114.
- Uziel G, Garavaglia B, Ciceri E, et al. Riboflavin-responsive glutaric aciduria type II presenting as a leukodystrophy. Pediat Neurol. 1995;13(4):333–335.
- Touat M, Michaud M, Alamowitch S, et al. Encephalopathy associated with a reversible splenial lesion in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency. Revue Neurol. 2018;174(10):747–750.
- Powell BR, Kennaway NG, Rhead WJ, et al. Juvenile multiple sclerosis-like episodes associated with a defect of mitochondrial beta oxidation. Neurology 1990;40(3, Part 1):487–491.
- Liang WC, Nishino I. Lipid storage myopathy. Curr Neurol Neurosci Rep. 2011;11(1):97–103.
- Angelini C. Spectrum of metabolic myopathies. Biochim Biophys Acta 2015;1852(4):615–621.
- Vasiljevski ER, Summers MA, Little DG, et al. Lipid storage myopathies: Current treatments and future directions. Prog Lipid Res. 2018;72:1–17.
- Liu XY, Jin M, Wang ZQ, et al. Skeletal muscle magnetic resonance imaging of the lower limbs in late-onset lipid storage myopathy with electron transfer flavoprotein dehydrogenase gene mutations. Chin Med J. 2016;129(12):1425–1431.
- Zhao YW, Liu XJ, Zhang W, et al. Muscle magnetic resonance imaging for the differentiation of multiple acyl-CoA dehydrogenase deficiency and immune-mediated necrotizing myopathy. Chin Med J. 2018;131(2):144–150.
- McMahon CJ, Wu JS, Eisenberg RL. Muscle edema. Am J Roentgenol. 2010;194(4):W284–W292.
- Hong DJ, Zhu M, Zhu ZJ, et al. Clinical and muscle magnetic resonance image findings in patients with late-onset multiple acyl-CoA dehydrogenase deficiency. Chin Med J. 2019;132(3):275–284.
- Stramare R, Beltrame V, Dal Borgo R, et al. MRI in the assessment of muscular pathology: A comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. Radiol Med. 2010;115(4):585–599.
- Heard H, Barker J. Recognizing, diagnosing, and treating rhabdomyolysis. JAAPA 2016;29(5):29–32.
- Huerta-Alardin AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis – an overview for clinicians. Crit Care 2005;9:158–169.
- Sauret JM, Marinides G, Wang GK. Rhabdomyolysis. Am Family Phys. 2002;65(5):907–912.
- Rosenbohm A, Sussmuth SD, Kassubek J, et al. Novel ETFDH mutation and imaging findings in an adult with glutaric aciduria type II. Muscle Nerve 2014;49:446–450.
- Izumi R, Suzuki N, Nagata M, et al. A case of late onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency manifesting as recurrent rhabdomyolysis and acute renal failure. Intern Med. 2011;50(21):2663–2668.
- Behin A, Acquaviva-Bourdain C, Souvannanorath S, et al. Multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of late-onset treatable metabolic disease. Revue Neurol. 2016;172:231–241.
- Caux F, Selma ZB, Laroche L, et al. CGI-58/ABHD5 gene is mutated in Dorfman-Chanarin syndrome. Am J Med Genet. 2004;129(2):214–214.
- Akiyama M, Sawamura D, Nomura Y, et al. Truncation of CGI-58 protein causes malformation of lamellar granules resulting in ichthyosis in Dorfman-Chanarin syndrome. J Investig Dermatol. 2003;121(5):1029–1034.
- Pujol RM, Gilaberte M, Toll A, et al. Erythrokeratoderma variabilis-like ichthyosis in Chanarin-Dorfman syndrome. Br J Dermatol. 2005;153(4):838–841.
- Srebrnik A, Brenner S, Ilie B, et al. Dorfman-Chanarin syndrome: morphologic studies and presentation of new cases. Am J Dermatopathol. 1998;20(1):79–85.
- Garibaldi M, Tasca G, Diaz-Manera J, et al. Muscle MRI in neutral lipid storage disease (NLSD). J Neurol. 2017;264(7):1334–1342.
- Mogahed EA, El-Hennawy A, El-Sayed R, et al. Chanarin-Dorfman syndrome: A case report and review of the literature. Arab J Gastroenterol. 2015;16:142–144.
- Srebrnik A, Tur E, Perluk C, et al. Dorfman-Chanarin syndrome. A case report and a review. J Am Acad Dermatol. 1987;17(5):801–808.
- Thakur K, Tomar SK, Singh AK, et al. Riboflavin and health: a review of recent human research. Crit Rev Food Sci Nutr. 2017;57(17):3650–3660.